-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
AbCellera Biologics Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2019 to 2023.
- AbCellera Biologics Inc. Amortization of Intangible Assets for the quarter ending March 31, 2024 was $1.69M, a 36.4% decline year-over-year.
- AbCellera Biologics Inc. annual Amortization of Intangible Assets for 2023 was $11.6M, a 10.5% increase from 2022.
- AbCellera Biologics Inc. annual Amortization of Intangible Assets for 2022 was $10.5M, a 3.96% increase from 2021.
- AbCellera Biologics Inc. annual Amortization of Intangible Assets for 2021 was $10.1M, a 304% increase from 2020.
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)